Yuliya A. Marsyanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yuliya A. Marsyanova has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Valentina I. Zvyagina
Ryazan State Medical University Ministry of Health of Russia; 9 Visokovoltnaya St., Ryazan, 390026, Russian Federation
12 shared publications - Dmitry R. Shodiev
Ryazan State Medical University
3 shared publications - Eduard S. Bel'SKikh
Ryazan State Medical University named after academician I.P. Pavlov
3 shared publications Марсянова Юлия Александровна
Рязанский государственный медицинский университет имени академика И. П. Павлова
3 shared publications- Anna M. Shitikova
Ryazan State Medical University
2 shared publications - Mikhail Mikhailovich Atroshchenko
All-Russian Research Institute for Horse Breeding
2 shared publications
Latest Publications
- 7 July 2026
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
METHOD FOR MODELING MILD AND MODERATE FORMS OF HYPERHOMOCYSTEINEMIA IN MALE RATS BY ORAL ADMINISTRATION OF D,L-HOMOCYSTEINE TOIOLACTONE
Introduction. Hyperhomocysteinemia is an independent risk factor for the development of cardiovascular and neurological diseases, as well as re-productive system pathology, which underscores the need for an in-depth study of its pathogenesis. The diversity of etiological factors of hyperhomo-cysteinemia, including genetic predispositions, B vitamin deficiencies, and comorbid conditions, complicates the prediction and management of this state, necessitating the development of adequate experimental models. Existing approaches to modeling hyperhomocysteinemia have a number of methodological limitations, which highlights the importance of creating a reproducible, minimally invasive, and clinically relevant model for investigat-ing the mechanisms of damage and discovering effective methods for therapeutic correction. Objective – to develop a reproducible model of hyperhomocysteinemia (Hcy) in rats. Material and Methods. The study was conducted on adult male Wistar rats (410–430 g) in four groups: control group (n=8), group 2 (n=8) receiving D,L-homocysteine thiolactone (D,L-HT) solution at a dose of 1 g/kg for 7 days, group 3 (n=8) receiving the same dose for 14 days, and group 4 (n=8) receiving D,L-HT at a dose of 3 g/kg for 7 days. D,L-HT solution was administered twice daily with a 7-hour interval. Results. The method of modeling Hcy through intragastric administration of D,L-HT at a dose of 1 g/kg for 7 and 14 days increased homocysteine levels by 4.9 and 7.9 times, respectively (p < 0.05), achieving mild and moderate Hcy. Administration at 3 g/kg elevated Hcy levels by 5.6 times but was associated with high mortality. Conclusion. The method of administering D,L-HT at a dose of 1 g/kg twice daily for 7 and 14 days is effective in modeling mild and moderate Hcy forms, suitable for studying the biological effects of elevated Hcy levels and testing pharmacological interventions
- 7 July 2026
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
METHOD FOR MODELING MILD AND MODERATE FORMS OF HYPERHOMOCYSTEINEMIA IN MALE RATS BY ORAL ADMINISTRATION OF D,L-HOMOCYSTEINE TOIOLACTONE
Introduction. Hyperhomocysteinemia is an independent risk factor for the development of cardiovascular and neurological diseases, as well as re-productive system pathology, which underscores the need for an in-depth study of its pathogenesis. The diversity of etiological factors of hyperhomo-cysteinemia, including genetic predispositions, B vitamin deficiencies, and comorbid conditions, complicates the prediction and management of this state, necessitating the development of adequate experimental models. Existing approaches to modeling hyperhomocysteinemia have a number of methodological limitations, which highlights the importance of creating a reproducible, minimally invasive, and clinically relevant model for investigat-ing the mechanisms of damage and discovering effective methods for therapeutic correction. Objective – to develop a reproducible model of hyperhomocysteinemia (Hcy) in rats. Material and Methods. The study was conducted on adult male Wistar rats (410–430 g) in four groups: control group (n=8), group 2 (n=8) receiving D,L-homocysteine thiolactone (D,L-HT) solution at a dose of 1 g/kg for 7 days, group 3 (n=8) receiving the same dose for 14 days, and group 4 (n=8) receiving D,L-HT at a dose of 3 g/kg for 7 days. D,L-HT solution was administered twice daily with a 7-hour interval. Results. The method of modeling Hcy through intragastric administration of D,L-HT at a dose of 1 g/kg for 7 and 14 days increased homocysteine levels by 4.9 and 7.9 times, respectively (p < 0.05), achieving mild and moderate Hcy. Administration at 3 g/kg elevated Hcy levels by 5.6 times but was associated with high mortality. Conclusion. The method of administering D,L-HT at a dose of 1 g/kg twice daily for 7 and 14 days is effective in modeling mild and moderate Hcy forms, suitable for studying the biological effects of elevated Hcy levels and testing pharmacological interventions
- 24 December 2025
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 15 (4) , 223-231
The Signaling Role of Several Mitochondrial Metabolites in the Regulation of Mitochondrial Homeostasis
This review systematizes contemporary data on the signaling role of mitochondrial metabolites in regulating mitochondrial homeostasis, with an emphasis on their influence on cellular adaptation to stress factors, including age-related changes. Mitochondria function not only as energy sources but also as key sensors and regulators, mediating anterograde and retrograde signaling through metabolites such as citrate, succinate, lactate, and L-carnitine. Citrate and succinate participate in epigenetic modifications, including protein acetylation and succinylation, thereby influencing gene expression and metabolic adaptation, with potential applications in the therapy of oncological and age-associated diseases. Lactate, traditionally regarded as a product of anaerobic metabolism, acts as a signaling molecule that modulates receptor cascades (GPR81), histone lactylation, and oxidative phosphorylation in mitochondria. L-carnitine ensures metabolic flexibility by maintaining the acyl-CoA/CoA balance, removing toxic metabolites, and enhancing nitric oxide bioavailability, demonstrating its protective effects in models of hyperhomocysteinemia and NO deficiency. Understanding these mechanisms opens up prospects for the identification of biomarkers of mitochondrial dysfunction and the development of therapeutic strategies aimed at restoring homeostasis in the context of aging, metabolic disorders, and gerontological syndromes.
- 24 December 2025
- Published by Pleiades Publishing Ltd in Advances in Gerontology
- Vol. 15 (4) , 223-231
The Signaling Role of Several Mitochondrial Metabolites in the Regulation of Mitochondrial Homeostasis
This review systematizes contemporary data on the signaling role of mitochondrial metabolites in regulating mitochondrial homeostasis, with an emphasis on their influence on cellular adaptation to stress factors, including age-related changes. Mitochondria function not only as energy sources but also as key sensors and regulators, mediating anterograde and retrograde signaling through metabolites such as citrate, succinate, lactate, and L-carnitine. Citrate and succinate participate in epigenetic modifications, including protein acetylation and succinylation, thereby influencing gene expression and metabolic adaptation, with potential applications in the therapy of oncological and age-associated diseases. Lactate, traditionally regarded as a product of anaerobic metabolism, acts as a signaling molecule that modulates receptor cascades (GPR81), histone lactylation, and oxidative phosphorylation in mitochondria. L-carnitine ensures metabolic flexibility by maintaining the acyl-CoA/CoA balance, removing toxic metabolites, and enhancing nitric oxide bioavailability, demonstrating its protective effects in models of hyperhomocysteinemia and NO deficiency. Understanding these mechanisms opens up prospects for the identification of biomarkers of mitochondrial dysfunction and the development of therapeutic strategies aimed at restoring homeostasis in the context of aging, metabolic disorders, and gerontological syndromes.
- Open Access
- 31 August 2025
- Published by Science and Innovation Center in Siberian Journal of Life Sciences and Agriculture
- Vol. 17 (3) , 500-528
Possibilities of using protein electrophoresis to assess metabolism in horses (literature review)
Background.Electrophoresis is a common and effective method for assessing the protein profile of humans and animals. The method of protein separation by electrophoresis has been well established since its discovery and has been developed and improved over several decades. At the present stage this procedure does not lose its relevance and finds new areas of application. Purpose.To study and analyze the accumulated experience in the application of protein detection methods by electrophoresis, in particular for the assessment of equine metabolism. Materials and methods.Literature search was performed by keywords using open databases: PubMed, eLibrary, Scopus, and Google Academic search engine. The most significant works on the topic of the review were selected and analyzed. Results.The molecular weight, size and shape of the molecule as well as its total charge are the main factors that make it possible to separate complex mixtures into separate fractions due to differences in their velocity. Successful separation of protein mixtures is influenced not only by the nature of the proteins, but also by the supporting medium, which must fulfill important characteristics: maintain optimal pH and allow molecules to pass through at a certain speed. Protein detection methods are as varied as the separation methods: non-selective staining with Coomassie brilliant blue, amido black 10B, silver, fluorescent dyes, and selective by immunoprecipitation or enzyme electrophoresis. The evaluation of equine metabolism by electrophoresis extends to virtually all areas of study: establishing seasonal and age-related changes; analyzing breed, subpopulation and hybrid traits; evaluating markers of inflammation, certain pathologies such as ulceration, uveitis, parasitic and viral infections, myopathies, and markers of animal fitness. In animal reproduction, electrophoresis can be used to assess the quality of ejaculate, to determine the ability of semen to freeze, to detect the viability of spermatozoa, including after cryopreservation, and to detect changes during mare foaling. Conclusion.The electrophoresis method is widely used in the assessment of human and animal metabolism, including horses. It has a high degree of significance for the analysis of population, age-sex and seasonal differences in horses, and also finds its application in the assessment of animal performance and reproductive technologies.
- 31 August 2025
- Published by Science and Innovation Center in Siberian Journal of Life Sciences and Agriculture
- Vol. 17 (3) , 500-528
Open AccessPossibilities of using protein electrophoresis to assess metabolism in horses (literature review)
Background.Electrophoresis is a common and effective method for assessing the protein profile of humans and animals. The method of protein separation by electrophoresis has been well established since its discovery and has been developed and improved over several decades. At the present stage this procedure does not lose its relevance and finds new areas of application. Purpose.To study and analyze the accumulated experience in the application of protein detection methods by electrophoresis, in particular for the assessment of equine metabolism. Materials and methods.Literature search was performed by keywords using open databases: PubMed, eLibrary, Scopus, and Google Academic search engine. The most significant works on the topic of the review were selected and analyzed. Results.The molecular weight, size and shape of the molecule as well as its total charge are the main factors that make it possible to separate complex mixtures into separate fractions due to differences in their velocity. Successful separation of protein mixtures is influenced not only by the nature of the proteins, but also by the supporting medium, which must fulfill important characteristics: maintain optimal pH and allow molecules to pass through at a certain speed. Protein detection methods are as varied as the separation methods: non-selective staining with Coomassie brilliant blue, amido black 10B, silver, fluorescent dyes, and selective by immunoprecipitation or enzyme electrophoresis. The evaluation of equine metabolism by electrophoresis extends to virtually all areas of study: establishing seasonal and age-related changes; analyzing breed, subpopulation and hybrid traits; evaluating markers of inflammation, certain pathologies such as ulceration, uveitis, parasitic and viral infections, myopathies, and markers of animal fitness. In animal reproduction, electrophoresis can be used to assess the quality of ejaculate, to determine the ability of semen to freeze, to detect the viability of spermatozoa, including after cryopreservation, and to detect changes during mare foaling. Conclusion.The electrophoresis method is widely used in the assessment of human and animal metabolism, including horses. It has a high degree of significance for the analysis of population, age-sex and seasonal differences in horses, and also finds its application in the assessment of animal performance and reproductive technologies.
- 19 July 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 74-82
Russian University of Medicine; Dolgorukovskaya ul., 4, Moscow, 127006, Russian Federation
Introduction. The high prevalence of obesity increases the importance of understanding the control of disease progression and associated metabolic abnormalities. Recent studies have revealed melatonin as a cause of degenerative joint diseases and a molecular link between sleep disorders and metabolic diseases, due to its powerful biological functions that have a specific effect on the metabolism of osteochondral tissue. Thus, melatonin plays an important role in the regulation of the sleep/wake cycle, adaptation to environmental changes and is considered a key mediator of pathologi-cal processes such as osteoarthritis. Aim – to assess the severity of somnological disorders and the level of nocturnal secretion of the pineal hormone melatonin in patients with the meta-bolic phenotype of osteoarthritis. Material and Methods. 80 patients has took part in the study. Participants were divided into 2 groups: group 1 – patients without joint pathology and normal body mass index; group 2 - patients with the metabolic phenotype of osteoarthritis. The subjects underwent a collection of complaints, anam-nesis, as well as a general clinical and orthopedic examination. Serum melatonin levels were determined. Results. Patients with the metabolic phenotype of osteoarthritis showed dysfunction in scores on the subcomponents of sleep quality and quantity. Patients demonstrated a tendency to daytime sleepiness, dissatisfaction with sleep duration, and frequent awakenings at night, which may be due to pain and symptoms of osteoarthritis. It was found that patients with the metabolic phenotype of osteoarthritis showed a decrease in nocturnal excre-tion of the pineal gland hormone melatonin in comparison with patients in group 1. Conclusions. The findings support the growing evidence of a significant interaction between melatonin secretion and metabolically associated diseas-es.
- 19 July 2025
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 74-82
Russian University of Medicine; Dolgorukovskaya ul., 4, Moscow, 127006, Russian Federation
Introduction. The high prevalence of obesity increases the importance of understanding the control of disease progression and associated metabolic abnormalities. Recent studies have revealed melatonin as a cause of degenerative joint diseases and a molecular link between sleep disorders and metabolic diseases, due to its powerful biological functions that have a specific effect on the metabolism of osteochondral tissue. Thus, melatonin plays an important role in the regulation of the sleep/wake cycle, adaptation to environmental changes and is considered a key mediator of pathologi-cal processes such as osteoarthritis. Aim – to assess the severity of somnological disorders and the level of nocturnal secretion of the pineal hormone melatonin in patients with the meta-bolic phenotype of osteoarthritis. Material and Methods. 80 patients has took part in the study. Participants were divided into 2 groups: group 1 – patients without joint pathology and normal body mass index; group 2 - patients with the metabolic phenotype of osteoarthritis. The subjects underwent a collection of complaints, anam-nesis, as well as a general clinical and orthopedic examination. Serum melatonin levels were determined. Results. Patients with the metabolic phenotype of osteoarthritis showed dysfunction in scores on the subcomponents of sleep quality and quantity. Patients demonstrated a tendency to daytime sleepiness, dissatisfaction with sleep duration, and frequent awakenings at night, which may be due to pain and symptoms of osteoarthritis. It was found that patients with the metabolic phenotype of osteoarthritis showed a decrease in nocturnal excre-tion of the pineal gland hormone melatonin in comparison with patients in group 1. Conclusions. The findings support the growing evidence of a significant interaction between melatonin secretion and metabolically associated diseas-es.
- 1 September 2024
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 41-49
SUCCINATE-RECEPTOR SYSTEM OF BONE AND CARTILAGE TISSUE IN PATIENTS WITH METABOLIC PHENOTYPE OF OSTEOARTHRITIS
Introduction. Melatonin, by inducing the expression of antioxidant enzymes and signaling proteins, enhances the effects in the development of pathological processes occurring against the background of oxidative stress, therefore the stabilization of the protective principles of melatonin is a rel-evant area of research, allowing us to identify new ways of development and treatment of osteoarthritis. The aim. To study the effect of melatonin on the succinate receptor system of chondrocytes in osteoarthritis under conditions of oxidative stress in vitro. Materials and methods. The in vitro study was carried out on chondrocyte cell cultures. Melatonin was added to chondrocytes to obtain final con-centrations of 100 μM and 500 μM; and hydrogen peroxide (H2O2) – 200 µM. The duration of exposure was 24 hours for melatonin and 12 hours for H2O2. Succinate levels and expression of its receptor (SUCNR1) were determined in mitochondria and chondrocyte lysates. Results. It was found that the addition of H2O2 at a dose of 200 μM to the nutrient medium for 12 hours led to a fold increase in the level of succinate and SUCNR1 expression in chondrocyte cells. Pre-incubation of chondrocyte cells with melatonin at concentrations of 100 µM and 500 µM, followed by modeling of oxidative stress (H2O2 200 µM) led to a decrease in the expression of the succinate receptor system. Conclusion. When Н2О2 is added to the cellular environment of chondrocytes, high expression of SUCNR1 and an increase in succinate levels are ob-served. Melatonin treatment limits Н2О2-induced succinate accumulation and reduces SUCNR1 expression in human chondrocyte cells of the metabolic phenotype of osteoarthritis
- 1 September 2024
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 41-49
SUCCINATE-RECEPTOR SYSTEM OF BONE AND CARTILAGE TISSUE IN PATIENTS WITH METABOLIC PHENOTYPE OF OSTEOARTHRITIS
Introduction. Melatonin, by inducing the expression of antioxidant enzymes and signaling proteins, enhances the effects in the development of pathological processes occurring against the background of oxidative stress, therefore the stabilization of the protective principles of melatonin is a rel-evant area of research, allowing us to identify new ways of development and treatment of osteoarthritis. The aim. To study the effect of melatonin on the succinate receptor system of chondrocytes in osteoarthritis under conditions of oxidative stress in vitro. Materials and methods. The in vitro study was carried out on chondrocyte cell cultures. Melatonin was added to chondrocytes to obtain final con-centrations of 100 μM and 500 μM; and hydrogen peroxide (H2O2) – 200 µM. The duration of exposure was 24 hours for melatonin and 12 hours for H2O2. Succinate levels and expression of its receptor (SUCNR1) were determined in mitochondria and chondrocyte lysates. Results. It was found that the addition of H2O2 at a dose of 200 μM to the nutrient medium for 12 hours led to a fold increase in the level of succinate and SUCNR1 expression in chondrocyte cells. Pre-incubation of chondrocyte cells with melatonin at concentrations of 100 µM and 500 µM, followed by modeling of oxidative stress (H2O2 200 µM) led to a decrease in the expression of the succinate receptor system. Conclusion. When Н2О2 is added to the cellular environment of chondrocytes, high expression of SUCNR1 and an increase in succinate levels are ob-served. Melatonin treatment limits Н2О2-induced succinate accumulation and reduces SUCNR1 expression in human chondrocyte cells of the metabolic phenotype of osteoarthritis
- 10 April 2024
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- Vol. 27 (4) , 42-49
SUCCINATE-RECEPTOR SYSTEM OF BONE AND CARTILAGE TISSUE IN PATIENTS WITH METABOLIC PHENOTYPE OF OSTEOARTHRITIS
Introduction. Currently, osteoarthritis (OA) has been identified as a polyetiological disease, where several phenotypes have been identified based on the leading frequency. Obviously, each clinical phenotype corresponds only to its fundamental changes on the part of various organs and systems. Un-til recently, special attention was paid to the study of metabolic processes in osteoarthritis (OA) and was paid to the state of the cartilage, but more and more interest was focused on the biochemistry of the subchondral bone, its microarchitectonics and signal function. Aid. To study the features of the manifestation of the succinate-receptor system of bone and cartilage tissue in patients with the metabolic phenotype of osteoarthritis. Material and methods. 42 patients took part in the study and were divided into 2 groups: 1 group – patients without articular disease, normal body mass index; 2 group – patients with metabolic phenotype of OA. The subjects were collected complaints, anamnesis, as well as general clinical and orthopedic examination. The levels of succinate, succinate receptor (SUCNR1) and succinate dehydrogenase (SDH) are measured in bone and cartilage tissue homogenates. Results. In the 2 group, an increase in SUCNR1 expression was detected in all studied areas of the joint in comparison with the 1 group. In the 2 group, the differences were tissue-specific in the distribution of SUCNR1 with a predominant increase in the amount of the receptor in the subchondral bone compared to the loaded (p=0.031) and non-loaded zone of cartilage (p=0.001). In the 1 group, the studied areas of cartilage and bone did not dif-fer in the amount of SUCNR1 from each other. In the group of patients with the metabolic phenotype of OA, an increase in mitochondrial succinate was found both in the subchondral bone tissue and in different zones of cartilage compared to the 1 group. The final indicators of SDH activity in the mito-chondria of the studied joint zones that we obtained turned out to be low in both groups, however, relatively high enzyme activity was observed in the subchondral zone of the bone of the group of metabolic phenotype of OA. Conclusion. In patients with the metabolic phenotype of OA, high expression of SUCNR1 in joint tissues is observed, which is tissue-specific with a predominant increase in the amount of SUCNR1 in the subchondral bone. We found higher levels of succinate in the subchondral bone and cartilaginous areas of joints in patients with the metabolic phenotype of OA and suggest that the succinate-SUCNR1 interaction in affected joints in OA is adaptive in nature.
- 10 April 2024
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- Vol. 27 (4) , 42-49
SUCCINATE-RECEPTOR SYSTEM OF BONE AND CARTILAGE TISSUE IN PATIENTS WITH METABOLIC PHENOTYPE OF OSTEOARTHRITIS
Introduction. Currently, osteoarthritis (OA) has been identified as a polyetiological disease, where several phenotypes have been identified based on the leading frequency. Obviously, each clinical phenotype corresponds only to its fundamental changes on the part of various organs and systems. Un-til recently, special attention was paid to the study of metabolic processes in osteoarthritis (OA) and was paid to the state of the cartilage, but more and more interest was focused on the biochemistry of the subchondral bone, its microarchitectonics and signal function. Aid. To study the features of the manifestation of the succinate-receptor system of bone and cartilage tissue in patients with the metabolic phenotype of osteoarthritis. Material and methods. 42 patients took part in the study and were divided into 2 groups: 1 group – patients without articular disease, normal body mass index; 2 group – patients with metabolic phenotype of OA. The subjects were collected complaints, anamnesis, as well as general clinical and orthopedic examination. The levels of succinate, succinate receptor (SUCNR1) and succinate dehydrogenase (SDH) are measured in bone and cartilage tissue homogenates. Results. In the 2 group, an increase in SUCNR1 expression was detected in all studied areas of the joint in comparison with the 1 group. In the 2 group, the differences were tissue-specific in the distribution of SUCNR1 with a predominant increase in the amount of the receptor in the subchondral bone compared to the loaded (p=0.031) and non-loaded zone of cartilage (p=0.001). In the 1 group, the studied areas of cartilage and bone did not dif-fer in the amount of SUCNR1 from each other. In the group of patients with the metabolic phenotype of OA, an increase in mitochondrial succinate was found both in the subchondral bone tissue and in different zones of cartilage compared to the 1 group. The final indicators of SDH activity in the mito-chondria of the studied joint zones that we obtained turned out to be low in both groups, however, relatively high enzyme activity was observed in the subchondral zone of the bone of the group of metabolic phenotype of OA. Conclusion. In patients with the metabolic phenotype of OA, high expression of SUCNR1 in joint tissues is observed, which is tissue-specific with a predominant increase in the amount of SUCNR1 in the subchondral bone. We found higher levels of succinate in the subchondral bone and cartilaginous areas of joints in patients with the metabolic phenotype of OA and suggest that the succinate-SUCNR1 interaction in affected joints in OA is adaptive in nature.
- Open Access
- 12 October 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (3) , 345-356
Hypoxia-Like Effect of L-Arginine in Seminal Vesicle and Epididymis of Rats
INTRODUCTION: The effect of L-arginine on metabolic processes is mediated by nitric oxide (II), whose pool is regulated by several enzymes. In the literature, the mutual influence of oxygen deficit and NO production is described. Besides, both processes can be regulated by exogenous L-arginine. AIM: To evaluate participation of L-arginine in the development of adaptive response to chronic normobaric hypoxia of tissues of reproductive system of male rats and to study its influence on metabolic changes in normoxia. MATERIALS AND METHODS: The experiment was conducted on Wistar stock rats (males, n = 8) which were divided to the following groups: (1) animals receiving L-arginine injections of 500 mg/kg of body weight for 10 days; (2) animals of control group receiving 0.9% NaCl solution; (3) animals subjected to chronic normobaric hypoxia in a hermetic chamber, observed once a day for 14 days until the oxygen concentration in the air decreased by 10%; (4) animals of the control group observed in a ventilated chamber; (5) animals subjected to hypoxia and injections of L-arginine. The material for analysis was the mitochondria and mitochondria-free fraction of the cytoplasm of the seminal vesicles, of the head and tail of the epididymis. The parameters were evaluated photometrically using diagnostic and enzyme immunoassay kits. RESULTS: The animals receiving L-arginine showed increase in the amount of -subunit of hypoxia-induced factor in the cytoplasm of seminal vesicles by 132% (p = 0.01), in the tail of epididymis by 32% (p = 0.02) and reduction in mitochondria by 45% (p = 0.01) and 60% (p = 0,002), respectively, a decrease in succinate levels by 40% (p = 0.005) and 51% (p = 0.0009), an increase in the concentration of lactic acid in the cytoplasm by 194% (p = 0.03) and 253% (p = 0.018), a decrease in cytochrome oxidase activity from 0.96 [0.66; 1.69] RU/mg of protein to 0.27 [0.23; 0.32] (p = 0.0009) and from 1.04 [0.84; 1.33] to 0.26 [0.14; 0.37] (p = 0.003), relative to the control group. The observed changes are characteristic of the state of hypoxia and are explained by the cell switching over to glycolytic pathway of energy production, in contrast to mitochondrial pathway in normoxia. The combined effect of hypoxia and arginine partially enhanced each other's effects. CONCLUSION: L-arginine causes hypoxia-like state in cells through activating -subunit by hypoxia-induced factor, reducing cytochrome oxidase activity, increasing glycolysis, and also partially enhances the effects of chronic normobaric hypoxia.
- 12 October 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (3) , 345-356
Open AccessHypoxia-Like Effect of L-Arginine in Seminal Vesicle and Epididymis of Rats
INTRODUCTION: The effect of L-arginine on metabolic processes is mediated by nitric oxide (II), whose pool is regulated by several enzymes. In the literature, the mutual influence of oxygen deficit and NO production is described. Besides, both processes can be regulated by exogenous L-arginine. AIM: To evaluate participation of L-arginine in the development of adaptive response to chronic normobaric hypoxia of tissues of reproductive system of male rats and to study its influence on metabolic changes in normoxia. MATERIALS AND METHODS: The experiment was conducted on Wistar stock rats (males, n = 8) which were divided to the following groups: (1) animals receiving L-arginine injections of 500 mg/kg of body weight for 10 days; (2) animals of control group receiving 0.9% NaCl solution; (3) animals subjected to chronic normobaric hypoxia in a hermetic chamber, observed once a day for 14 days until the oxygen concentration in the air decreased by 10%; (4) animals of the control group observed in a ventilated chamber; (5) animals subjected to hypoxia and injections of L-arginine. The material for analysis was the mitochondria and mitochondria-free fraction of the cytoplasm of the seminal vesicles, of the head and tail of the epididymis. The parameters were evaluated photometrically using diagnostic and enzyme immunoassay kits. RESULTS: The animals receiving L-arginine showed increase in the amount of -subunit of hypoxia-induced factor in the cytoplasm of seminal vesicles by 132% (p = 0.01), in the tail of epididymis by 32% (p = 0.02) and reduction in mitochondria by 45% (p = 0.01) and 60% (p = 0,002), respectively, a decrease in succinate levels by 40% (p = 0.005) and 51% (p = 0.0009), an increase in the concentration of lactic acid in the cytoplasm by 194% (p = 0.03) and 253% (p = 0.018), a decrease in cytochrome oxidase activity from 0.96 [0.66; 1.69] RU/mg of protein to 0.27 [0.23; 0.32] (p = 0.0009) and from 1.04 [0.84; 1.33] to 0.26 [0.14; 0.37] (p = 0.003), relative to the control group. The observed changes are characteristic of the state of hypoxia and are explained by the cell switching over to glycolytic pathway of energy production, in contrast to mitochondrial pathway in normoxia. The combined effect of hypoxia and arginine partially enhanced each other's effects. CONCLUSION: L-arginine causes hypoxia-like state in cells through activating -subunit by hypoxia-induced factor, reducing cytochrome oxidase activity, increasing glycolysis, and also partially enhances the effects of chronic normobaric hypoxia.
- 5 January 2023
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 49-54
EFFECT OF MODULATION OF NITROGEN OXIDE (II) SYNTHESIS UNDER CHRONIC NORMOBARIC HYPOXIA ON THE ISOENZYME SPECTRUM OF RAT EPIDIDIMIS LACTATE DEHYDROGENASE
Lactate dehydrogenase have a key role in providing energy to cells under physiological and hypoxic conditions. Changes in the activity of the enzyme can be facilitated by nitric oxide (II), regulating the expression of individual fractions of lactate dehydrogenase. Aim. To study changes in the isoenzyme spectrum of rat epididymis lactate dehydrogenase under conditions of hypoxia and modulation of nitric oxide (II) synthesis. Material and methods. Male rats (32) were divided into 4 groups (n=8): 1) chronic normobaric hypoxia; 2) control to group 1; 3) hypoxia together with modeling of nitric oxide deficiency; 4) hypoxia against the background of induction of NO synthesis. The mitochondrial fraction and non-mitochondrial cytoplasm of the head and tail of the epididymis were isolated for laboratory research. The zymogram was obtained by electrophoresis in 7% gel followed by detection by the precipitation reaction of the reduction of nitro blue tetrazolium. The overall activity of lactate dehydrogenase was assessed and the percentage of isoenzyme fractions was calculated. Fractions 1 and X of lactate dehydrogenase were analyzed, the results were con-sidered statistically significant if p 0.05 when comparing two independent samples, and p 0.0167 when comparing three independent samples. Results. Chronic normobaric hypoxia leads to a decrease in lactate dehydrogenase activity compared to the control group. At the same time, the share of the X-fraction of the enzyme and lactate dehydrogenase 1 increases. Modulation of nitric oxide (II) deficiency against the background of hy-poxia increased the activity of the enzyme in the head of the epididymis, where a decrease in the studied fractions of lactate dehydrogenase was ob-served compared to the group of animals subjected only to hypoxia. Stimulation of the synthesis of nitric oxide (II) during hypoxia led to a decrease in the X-fraction, but an increase in the 1st fraction of lactate dehydrogenase in the head of the epididymis, in the tail of the epididymis, opposite changes were observed. Conclusion. Hypoxia causes a change in the ratio of lactate dehydrogenase isoenzymes towards an increase in lactate dehydrogenase B and lactate dehydrogenase X, while a deficiency of nitric oxide (II) contributes to a decrease in lactate dehydrogenase X synthesis.
- 5 January 2023
- Published by Russian Vrach, Publishing House Ltd. in Problems of Biological, Medical and Pharmaceutical Chemistry
- p. 49-54
EFFECT OF MODULATION OF NITROGEN OXIDE (II) SYNTHESIS UNDER CHRONIC NORMOBARIC HYPOXIA ON THE ISOENZYME SPECTRUM OF RAT EPIDIDIMIS LACTATE DEHYDROGENASE
Lactate dehydrogenase have a key role in providing energy to cells under physiological and hypoxic conditions. Changes in the activity of the enzyme can be facilitated by nitric oxide (II), regulating the expression of individual fractions of lactate dehydrogenase. Aim. To study changes in the isoenzyme spectrum of rat epididymis lactate dehydrogenase under conditions of hypoxia and modulation of nitric oxide (II) synthesis. Material and methods. Male rats (32) were divided into 4 groups (n=8): 1) chronic normobaric hypoxia; 2) control to group 1; 3) hypoxia together with modeling of nitric oxide deficiency; 4) hypoxia against the background of induction of NO synthesis. The mitochondrial fraction and non-mitochondrial cytoplasm of the head and tail of the epididymis were isolated for laboratory research. The zymogram was obtained by electrophoresis in 7% gel followed by detection by the precipitation reaction of the reduction of nitro blue tetrazolium. The overall activity of lactate dehydrogenase was assessed and the percentage of isoenzyme fractions was calculated. Fractions 1 and X of lactate dehydrogenase were analyzed, the results were con-sidered statistically significant if p 0.05 when comparing two independent samples, and p 0.0167 when comparing three independent samples. Results. Chronic normobaric hypoxia leads to a decrease in lactate dehydrogenase activity compared to the control group. At the same time, the share of the X-fraction of the enzyme and lactate dehydrogenase 1 increases. Modulation of nitric oxide (II) deficiency against the background of hy-poxia increased the activity of the enzyme in the head of the epididymis, where a decrease in the studied fractions of lactate dehydrogenase was ob-served compared to the group of animals subjected only to hypoxia. Stimulation of the synthesis of nitric oxide (II) during hypoxia led to a decrease in the X-fraction, but an increase in the 1st fraction of lactate dehydrogenase in the head of the epididymis, in the tail of the epididymis, opposite changes were observed. Conclusion. Hypoxia causes a change in the ratio of lactate dehydrogenase isoenzymes towards an increase in lactate dehydrogenase B and lactate dehydrogenase X, while a deficiency of nitric oxide (II) contributes to a decrease in lactate dehydrogenase X synthesis.
- Open Access
- 28 December 2022
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 30 (4) , 457-470
Protective Effects of L-Arginine on Mitochondria of Rat Epididymis in Hyperhomocysteinemia Induced by Prolonged Methionine Load
INTRODUCTION: The study of markers of oxidative stress, metabolites of nitric oxide (II) (NOx) and the balance of carnitine fractions in mitochondria of rat epididymis, permits to evaluate the protective role of L-arginine in experimental hyperhomocysteinemia. AIM: To study the influence of L-arginine on the parameters of energy metabolism, level of NO metabolites, oxidative modification of proteins and balance of carnitine fractions in mitochondria of the head and tail of rat epididymis in hyperhomocysteinemia. MATERIALS AND METHODS: In animals of group 1 (n = 8), severe hyperhomocysteinemia (HHcy) was modeled by administration of methionine suspension at a dose of 1.5 g/kg twice daily for 21 days with addition of 1% methionine in drinking water; group 2 rats (n = 8) received suspension base without methionine; animals of group 3 (n = 8) were daily administered L-arginine solution at a dose of 500 mg/kg intragastrically against the background methionine load from day 11 to day 21; group 4 animals (n = 8) were administered L-arginine solution of at a dose of 500 mg/kg for 10 days; group 5 (n = 8) served as a control for group 4 and received drinking water intragastrically. Concentrations of total homocysteine and NOx were determined in serum. In the mitochondrial fraction of the homogenate of epididymis tissues, the level of oxidatively modified proteins (OMP), the concentration of NOx, lactate and carnitine fractions, the activity of lactate dehydrogenase (LDH), superoxide dismutase (SOD), H+-ATPase, succinate dehydrogenase (SDH) were evaluated. RESULTS: HHcy was accompanied by reduction of the level of NOx in blood serum and mitochondria of epididymis head tissues. In mitochondria of tissues of head and tail of epididymis, a marked reduction of all fractions of carnitine, activity of LDH, H+-ATPase, SDH, increase in the activity of SOD and in the level of OMP were observed. With modeled HHcy, L-arginine reduced the extent of hyperhomocysteinemia, prevented reduction of NOx level in the blood serum and epididymis head and reduced the content of OMP of the epididymis mitochondria. CONCLUSION: L-arginine introduced in combination with methionine, reduces the extent of severity of hyperhomocysteinemia. The positive effect of L-arginine on increase in the concentration of NOx metabolites in blood serum and mitochondria of epididymis in conditions of methionine load was also confirmed. L-arginine exhibits antioxidant properties, reducing the severity of oxidative stress induced by hyperhomocysteinemia. Differences in the adaptive response to oxidative stress of the mitochondria of the head and tail of epididymis were demonstrated.
- 28 December 2022
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 30 (4) , 457-470
Open AccessProtective Effects of L-Arginine on Mitochondria of Rat Epididymis in Hyperhomocysteinemia Induced by Prolonged Methionine Load
INTRODUCTION: The study of markers of oxidative stress, metabolites of nitric oxide (II) (NOx) and the balance of carnitine fractions in mitochondria of rat epididymis, permits to evaluate the protective role of L-arginine in experimental hyperhomocysteinemia. AIM: To study the influence of L-arginine on the parameters of energy metabolism, level of NO metabolites, oxidative modification of proteins and balance of carnitine fractions in mitochondria of the head and tail of rat epididymis in hyperhomocysteinemia. MATERIALS AND METHODS: In animals of group 1 (n = 8), severe hyperhomocysteinemia (HHcy) was modeled by administration of methionine suspension at a dose of 1.5 g/kg twice daily for 21 days with addition of 1% methionine in drinking water; group 2 rats (n = 8) received suspension base without methionine; animals of group 3 (n = 8) were daily administered L-arginine solution at a dose of 500 mg/kg intragastrically against the background methionine load from day 11 to day 21; group 4 animals (n = 8) were administered L-arginine solution of at a dose of 500 mg/kg for 10 days; group 5 (n = 8) served as a control for group 4 and received drinking water intragastrically. Concentrations of total homocysteine and NOx were determined in serum. In the mitochondrial fraction of the homogenate of epididymis tissues, the level of oxidatively modified proteins (OMP), the concentration of NOx, lactate and carnitine fractions, the activity of lactate dehydrogenase (LDH), superoxide dismutase (SOD), H+-ATPase, succinate dehydrogenase (SDH) were evaluated. RESULTS: HHcy was accompanied by reduction of the level of NOx in blood serum and mitochondria of epididymis head tissues. In mitochondria of tissues of head and tail of epididymis, a marked reduction of all fractions of carnitine, activity of LDH, H+-ATPase, SDH, increase in the activity of SOD and in the level of OMP were observed. With modeled HHcy, L-arginine reduced the extent of hyperhomocysteinemia, prevented reduction of NOx level in the blood serum and epididymis head and reduced the content of OMP of the epididymis mitochondria. CONCLUSION: L-arginine introduced in combination with methionine, reduces the extent of severity of hyperhomocysteinemia. The positive effect of L-arginine on increase in the concentration of NOx metabolites in blood serum and mitochondria of epididymis in conditions of methionine load was also confirmed. L-arginine exhibits antioxidant properties, reducing the severity of oxidative stress induced by hyperhomocysteinemia. Differences in the adaptive response to oxidative stress of the mitochondria of the head and tail of epididymis were demonstrated.
- 2 December 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (6) , 976-985
Analysis of oxidative modification of rat epididymal mitochondrial proteins under normobaric chronic hypoxia and modulation of nitric oxide (II) synthesis
Background. The molecular mechanism of NO effects in adaptation to hypoxia is of interest as a potential point of application in the therapy of fertility disorders. Aim. To assess the degree of oxidative modification of epididymal mitochondrial proteins during hypoxia under conditions of experimentally modified NO synthesis. Material and methods. Sexually mature rats were divided into four groups of 8 individuals: (1) control (animals without hypoxia); (2) chronic normobaric hypoxia, the animals were kept in a sealed chamber with oxygen reduced to 10% once a day for 14 days; (3) animals with hypoxia were injected with an inhibitor of the synthesis of nitric oxide (II) L-nitroarginine methyl ester at a dose of 25 mg/kg intraperitoneally once a day for 7 days; (4) animals with hypoxia were injected with the substrate for NO synthesis L-arginine at a dose of 500 mg/kg intraperitoneally once a day for 10 days. In the mitochondrial fraction of the head and tail of the epididymis, the activity of superoxide dismutase, the amount of NO metabolites, and the degree of oxidative modification of proteins were evaluated. Statistical analysis was performed using the ShapiroWilk, MannWhitney, and Spearman tests; differences were considered significant at p 0.05. Results. Hypoxia led to an increase in the oxidative modification of proteins in the mitochondria of the head of the epididymis 319.12 [240.98; 363.63] c.u./mg protein relative to control 17.89 [15.31; 27.62] c.u./mg protein, p=0.0009. In the mitochondria of the tail of the epididymis, the oxidation of proteins under the studied conditions was less pronounced. The use of L-nitroarginine methyl ester, as well as L-arginine, led to a decrease in the level of oxidative modification of proteins in the head of the epididymis relative to the hypoxia model 39.89 [29.25; 43.17] and 37.25 [34.91; 40.96] c.u./mg of protein, respectively, p=0.0009. Conclusion. Mitochondrial proteins in the head of the epididymis are more susceptible to oxidative damage during hypoxia; a decrease in the level of NO metabolites under conditions of oxygen deficiency is associated with a decrease in the oxidative modification of mitochondrial proteins.
- 2 December 2022
- Published by ECO-Vector LLC in Kazan medical journal
- Vol. 103 (6) , 976-985
Analysis of oxidative modification of rat epididymal mitochondrial proteins under normobaric chronic hypoxia and modulation of nitric oxide (II) synthesis
Background. The molecular mechanism of NO effects in adaptation to hypoxia is of interest as a potential point of application in the therapy of fertility disorders. Aim. To assess the degree of oxidative modification of epididymal mitochondrial proteins during hypoxia under conditions of experimentally modified NO synthesis. Material and methods. Sexually mature rats were divided into four groups of 8 individuals: (1) control (animals without hypoxia); (2) chronic normobaric hypoxia, the animals were kept in a sealed chamber with oxygen reduced to 10% once a day for 14 days; (3) animals with hypoxia were injected with an inhibitor of the synthesis of nitric oxide (II) L-nitroarginine methyl ester at a dose of 25 mg/kg intraperitoneally once a day for 7 days; (4) animals with hypoxia were injected with the substrate for NO synthesis L-arginine at a dose of 500 mg/kg intraperitoneally once a day for 10 days. In the mitochondrial fraction of the head and tail of the epididymis, the activity of superoxide dismutase, the amount of NO metabolites, and the degree of oxidative modification of proteins were evaluated. Statistical analysis was performed using the ShapiroWilk, MannWhitney, and Spearman tests; differences were considered significant at p 0.05. Results. Hypoxia led to an increase in the oxidative modification of proteins in the mitochondria of the head of the epididymis 319.12 [240.98; 363.63] c.u./mg protein relative to control 17.89 [15.31; 27.62] c.u./mg protein, p=0.0009. In the mitochondria of the tail of the epididymis, the oxidation of proteins under the studied conditions was less pronounced. The use of L-nitroarginine methyl ester, as well as L-arginine, led to a decrease in the level of oxidative modification of proteins in the head of the epididymis relative to the hypoxia model 39.89 [29.25; 43.17] and 37.25 [34.91; 40.96] c.u./mg of protein, respectively, p=0.0009. Conclusion. Mitochondrial proteins in the head of the epididymis are more susceptible to oxidative damage during hypoxia; a decrease in the level of NO metabolites under conditions of oxygen deficiency is associated with a decrease in the oxidative modification of mitochondrial proteins.